Topnav

Archive | Archive

Adcock tackles opioid addiction

A half-day symposium, conceptualised and organised by Adcock Ingram Critical Care, brought thought leaders together to exchange learnings on the thorny problem of opioid addiction. Held at the OR Tambo conference venue on Saturday 28th January, the symposium attracted a high level audience of government officials and academics, among others.  (more…)

Continue Reading · 0

Reducing TB and HIV in SA’s prisons

Inmates and people who work at the Department of Correctional Services (DCS) are at high risk of contracting TB, which in turn can filter back into their communities. To address this serious issue, there is a large national TB programme underway, which helps to address TB risks in the prison system, where inmates and DCS […]

Continue Reading · 0

Self-screening takes the lead

Self-screening medical testing provider and South African company, UDoTest, was 1 of 13 leading South African medical technology entrepreneurs chosen by Discovery to partake in the first ever Discovery Entrepreneurs Medical Technology Programme, from November 27 to December 3, 2016. (more…)

Continue Reading · 0

SA’s trivial attitude to heart health

A survey conducted by Pharma Dynamics to determine how heart-aware South Africans are in the lead up to Valentine’s Day, revealed that nearly a quarter described their relationship with their hearts as ‘on the rocks’. (more…)

Continue Reading · 0

HPV: The facts

Here are some facts about human papillomavirus (HPV). HPV is a common virus that is transmitted sexually and by skin-to-skin contact.1 HPV can cause cancer in men and women, including cancers of the cervix, throat, anus, and penis. It is also the cause of genital warts.2 Some HPV types are responsible for warts, while others […]

Continue Reading · 0

SA’s first locally certified Urogynaecologist

A young Capetonian gynaecologist is on course to become SA’s first locally certified Urogynaecologist, and it won’t come a moment too soon for her two mentors and others in the field who have battled for years to see this ‘unsexy’ discipline get the recognition it deserves. (more…)

Continue Reading · 0

First co-formulation of an ultra-long-acting and a short-acting insulin analogue

Novo Nordisk recently presented the latest addition to their insulin portfolio. The first co-formulation of an ultra-long-acting and a short-acting insulin analogue, was introduced at the event attended by more than 550 doctors and colleagues. Attending the event at the Sandton Convention Centre, among some eminent local physicians, guests included Novo Nordisk Corporate Vice President […]

Continue Reading · 0